Myeloproliferative neoplasms: open trials in Romania

8 open trials have a site in Romania. Registry data; only the trial team decides who can take part.

NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Institutul Clinic Fundeni, Bucharest · Spitalul Clinic Colțea, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Spitalul Clinic Municipal De Urgenta Timisoara, Timisoara
Registry updated 2026-11-09
NCT07623161
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Trial Treatment · Phase 3 · Takeda
Spitalul Clinic Colentina Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Spitalul Clinic Municipal Filantropia Craiova, Craiova · Spitalul Clinic Municipal De Urgenta Timisoara, Timisoara
Registry updated 2026-11-06
NCT04176198
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
Onco Card S.R.L., Brasov
Registry updated 2026-10-02
2024-511309-47-00
A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor-naïve myelofibrosis and moderate thrombocytopenia.
Trial Treatment · Phase 2 · Karyopharm Therapeutics Inc.
Spitalul Clinic Colțea, Bucharest · Spitalul Clinic Municipal Filantropia Craiova, Craiova · Institutul Regional de Oncologie Iasi, Iași
Registry updated 2026-09-25
2023-504724-25-00
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Trial Treatment · Phase 3 · Kartos Therapeutics Inc.
Onco Card S.R.L., Brasov · Spitalul Clinic Colentina Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Spitalul Clinic Judetean De Urgenta Bihor, Oradea · Spitalul Clinic Judetean de Urgenta Targu Mures, Târgu Mureş
Registry updated 2026-09-14
NCT06533813
Clinical Epidemiology in Contemporary Patients With Myelofibrosis.
Research · FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Department of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest
Registry updated 2026-07-09
NCT05980806
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Trial Treatment · Phase 2 · Karyopharm Therapeutics Inc
Coltea - Spital Clinic, Bucharest · Spitalul Filantropia - Craiova, Craiova · Institutul Regional de Oncologie Iasi, Iași
Registry updated 2026-02-12
NCT06479135
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Trial Treatment · Phase 3 · Kartos Therapeutics, Inc.
Onco Card Srl, Brasov · Colentina Clinical Hospital, Department of Hematology, Bucharest · "Prof. Dr. Ion Chiricuta" Institute of Oncology, Hematology Department, Cluj-Napoca · Bihor County Emergency Clinical Hospital, Department of Hematology, Oradea · Targu Mures County Emergency Clinical Hospital, Internal Medicine Department I, Hematology Unit, Târgu Mureş
Registry updated 2025-09-25

All Myeloproliferative neoplasms trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error